logo
  • Home
  • Company
    • Management
    • Board of Directors
    • Governance
    • Medical and Scientific Advisory Board
  • Investors
    • Overview
    • News / Events
    • Shareholder Calls / Presentations
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • News & Media
    • Press Releases
    • Articles
    • Reports
    • Media
    • Photo Gallery
  • Contact
    • Social Media Community Guidelines

Press Releases

Navigation Toggle Navigation
  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Shareholder Calls / Presentations
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Quick Links
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • Nov 25, 2019

PharmaCyte Biotech “Release Testing” Successful on All Completed Tests of Clinical Trial Product

  • Nov 18, 2019

PharmaCyte Biotech Successfully Completes Final Manufacturing Run of Clinical Trial Product

  • Nov 12, 2019

PharmaCyte Biotech’s “Release Testing” Last Critical Event Before Submission of Investigational New Drug Application

  • Nov 4, 2019

PharmaCyte Biotech Closer to Submitting IND by Successfully Completing Encapsulation of Second Manufacturing Run of Clinical Trial Product

  • Oct 28, 2019

PharmaCyte Biotech to Change Future of Treating Diseases with Validation of Encapsulation Technology in Pancreatic Cancer Trial

  • Oct 16, 2019

PharmaCyte Biotech Closer to Submitting IND with Successful Completion of Clinical Trial Product

  • Oct 14, 2019

PharmaCyte Biotech Successfully Completes Manufacturing of Clinical Trial Product

  • Oct 1, 2019

PharmaCyte Biotech Q&A Discussion with Cellular Biologist David A. Judd

  • Sep 25, 2019

PharmaCyte Biotech Releases Shareholder Update Call Playback Information

  • Sep 23, 2019

PharmaCyte Biotech's Pancreatic Cancer Therapy Production in Final Days of Key Manufacturing Run

RSS
  • « Previous
  • 1...
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • ...29
  • Next »

Contact Us

PharmaCyte Biotech, Inc.
3960 Howard Hughes Parkway, Suite 500
Las Vegas, Nevada 89169
Office Number: 917.595.2850
Facsimile Number: 917.595.2851
Email: info@PharmaCyte.com

Latest News

  • PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value October 7, 2022
  • PharmaCyte Biotech Reaches Cooperation Agreement with Iroquois Capital August 15, 2022